Yung Shin Pharmaceutical Industrial Co Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VORICONAZOLE "YUNG SHIN", with a corresponding US DMF Number 33830.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 24, 2019, and payment made on September 27, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II